Vistagen Therapeutics Inc —— 季度财务数据 (NASDAQ:VTGN) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -10.06 M-18.85 M-13.76 M-17.63 M -60.3 M 投资活动产生的现金 527 K-788 K-94 K104 K -251 K 融资活动产生的现金 1.95 M1.49 M27.65 M2.11 M 33.2 M 自由现金流 -10.06 M-18.91 M-13.82 M-17.66 M -60.45 M

新闻

Vistagen Therapeutics裁员20%以控制成本

Vistagen Therapeutics reduces workforce by 20 percent to manage costs

VistaGen在TD Cowen大会上展示:聚焦信息素平台技术

VistaGen at TD Cowen Conference: Pherine Platform in Focus

Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call Transcript

VistaGen Therapeutics 2026年第三季度财报电话会议：AI驱动的试验分析亮点

Earnings call transcript: VistaGen Therapeutics Q3 2026 highlights AI-driven trial analysis

VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue Estimates

Vistagen Therapeutics公司的fasedienol三期临床试验未达终点

Vistagen Therapeutics reports Phase 3 trial for fasedienol did not meet endpoint

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%

美国股市收低；截至收盘道琼斯工业平均指数下跌0.47%